Single Cell Analysis Market

Single Cell Analysis Market Research, 2031

The global single cell analysis market size was valued at $2.64 billion in 2021, and is projected to reach $13.62 billion by 2031, growing at a CAGR of 17.8% from 2022 to 2031. Single-cell analysis (SCA) is of critical importance in revealing population heterogeneity, identifying minority sub-populations of interest, as well as discovering unique characteristics of individual cells. Microfluidic platforms of single cell analysis work at the scale comparable to cell diameter and are suitable for single-cell manipulation. A microfluidic trapping array which is able to rapidly and deterministically trap single-cells in highly-packed microwells. As the single-cell trapping efficiency is determined by the channel design instead of the flow rate, this trapping array can be coupled with different microfluidic sample processing units with different flow rates for various single-cell analyses. In addition, SCA is widely applied to immunology, microbiology, neurobiology, prenatal diagnosis, embryogenesis, and plant biology.

The COVID-19 outbreak had a positive impact on the single cell analysis market. Governments all over the world have increased financing for vaccine development and manufacturing as a result of the pandemic's economic and social costs, which has led to an increase in the usage of single-cell analytic tools for COVID-19 research.

Increase in demand for single cell analysis is anticipated to increase globally during the forecast period, owing to technological advancement in single cell analysis coupled with increase in R&D in pharmaceutical and biotechnology industry whci also boost single cell analysis market growth. Moreover, growth in stem cell research, rise in focus on personalized medicines and surge in prevalence of cancer further drive the growth of single cell analysis market. However, high cost of single cell analysis products is anticipated to hamper the market growth. Conversely, high growth potential of single cell sequencing is expected to offer lucrative growth opportunities for the key player in the market during single cell analysis market forecast. 

COVID-19 Impact Analysis
Coronavirus (COVID-19) was discovered in December 2019, in Hubei province of Wuhan city in China. A virus, severe acute respiratory syndrome coronavirus 2, causes the disease (SARS-CoV-2), which transmitted among humans. 
The disease rapidly spread to other parts of the globe post its discovery in Wuhan. Moreover, this virus causes various symptoms in patients, which range from common symptoms to serious symptoms. For instance, common symptoms include fever, dry cough, and fatigue. However, serious symptoms include difficulty in breathing or shortness of breath, chest pain, and loss of speech or movement. Furthermore, the virus has high potential of lethality in geriatric population. On March 11, 2020, the World Health Organization declared it as a pandemic. In addition, there are only a few vaccines that received emergency approvals for COVID-19 prevention. Thus, social distancing is observed as the most important measure to limit the spread of this disease. Furthermore, to maintain social distancing in various countries across the globe have led to adoption of lockdowns. 

The COVID-19 outbreak had a positive impact on the single cell analysis industry. Governments all over the world have increased financing for vaccine development and manufacturing as a result of the pandemic's economic and social costs, which has led to an increase in the usage of single-cell analytic tools for COVID-19 research. Although the government imposed a number of restrictions that had an impact on overall production and sales, the demand for single-cell analysis products surged. A deeper comprehension of the host immune response during illness progression is essential in order to more accurately construct prognostic and diagnostic indicators and establish suitable therapeutic approaches for patients with severe disease presentation. Researchers can gain a better understanding of immune cells at the single-cell level and how functional cells contribute to immune protection by using the single-cell analysis, how the development of more efficient vaccines and immunotherapies is made possible by understanding how functioning cells contribute to immune protection and disease.

Therefore, the market is anticipated to have significant possibilities for growth during the pandemic and provide single cell analysis market opportunity, owing to increase in product demand and continuous research activities (by examining the application of the single-cell analysis approach in the SARS-CoV2).

Single Cell Analysis Market Segmentation 

The single cell analysis market is segmented on the basis of product, application, end user and region. On the basis of product, the market is classified into consumables and instruments. On the basis of application, it is segmented into oncology, immunology, neurology, stem cell, non-invasive prenatal diagnosis, in-vitro fertilization, others. According to technique, the market is categorized into flow cytometry, next generation sequencing, polymerase chain reaction, mass spectrometry and others. On the basis of end user, it is categorized into academic & research laboratories, biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories, cell banks & IVF centers. Furthermore, on the basis of region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Segment Review

By product, the single cell analysis market is divided into consumables and instruments. The consumables segment has largest market share as well as highest CAGR, and is anticipated to continue this trend during the forecast period, owing to high usability of products and frequent purchase of reagents, increase in prevalence of target diseases and constant need for consumables required for assay.

 

By application, the market is divided into oncology, immunology, neurology, stem cell, non-invasive prenatal diagnosis, in-vitro fertilization, others. The oncology segment was the major revenue contributor in 2021, and is anticipated to continue this trend during the forecast period, owing to increase in prevalence of cancer. In addition, single cell analysis proved to be effective for prior diagnostics of cancer cells, thus driving the segment growth.

By technique the market is divided into flow cytometry, next generation sequencing, polymerase chain reaction, mass spectrometry and others. The next generation sequencing segment was the major revenue contributor in 2021, and is anticipated to continue this trend during the forecast period, owing to increase in genome mapping programs, rise in applications of next generation sequencing, increase in healthcare expenditure and technological advancements in sequencing platforms, thus driving the segment growth.

By end user, the market is divided into academic & research laboratories, biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories, cell banks & IVF centers.  The biotechnology & pharmaceutical companies segment was the major single cell analysis market share 2021, and is anticipated to continue this trend during the forecast period, owing to technological advancement such as the use of microfluidics for the development of next generation therapies have increased the adoption of single cell analysis by biotechnology and pharmaceutical companies.

By region, the single cell analysis market is analyzed across North America, Asia-Pacific, Europe, and LAMEA. North America dominated the single cell analysis market size in 2021, accounting for the highest share, and is anticipated to maintain this trend during the forecast period. This is attributed to the rise in well-established healthcare system, increase in number of geriatric patients and supportive reimbursement policies in healthcare system propel the market growth.

 

The major companies profiled in the report include Becton, Dickinson and Company, Danaher Corporation, Merck KGAA, QIAGEN N.V., Thermo Fisher Scientific, Inc., 10x Genomics, Illumina, Inc., Bio-Rad Laboratories, Agilent Technologies, Inc., Sartorius AG, Takara Holdingsinc, Oxford Nanopore Technologies., Berkley Light INC., BGI Genomics Co.Ltd., Diasorin Group, Dolomite Bio, Standard Biotools.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the single cell analysis market analysis from 2021 to 2031 to identify the prevailing single cell analysis market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the single cell analysis market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global single cell analysis market trends, key players, market segments, application areas, and market growth strategies.

 Single Cell Analysis Market Report Highlights